Brianna Abbott

Uterine cancer will kill some 13,250 women in the U.S. this year, surpassing ovarian cancer to become the deadliest gynecologic cancer. And the reasons aren't entirely clear.

More patients can fend off the disease for months or years with targeted or immune-boosting drugs, results released this weekend at a top cancer conference showed.

There is more hope than ever for people diagnosed with the deadliest cancer.

Women nationwide will soon learn from test results whether they have dense breast tissue that puts them at higher risk.

Cancer is impacting the finances, relationships and futures of more young people

Vaccines designed to prevent cancer for high-risk groups are in early human trials.

Vaccines designed to prevent cancer for high-risk groups are in early human trials.

More drugs and changing guidelines are too much for general oncologists to track.

More people are navigating the burden of rebuilding lives after cancer.

Cancer survivorship has remarkably increased over the past couple of decades given the significant strides in medicine. Yet, it remains one of the key risks for life expectancy and quality of life in old age. So, it is encouraging to see possibilities of a vaccine for prevention.